Omonike Olaleye to Humans
This is a "connection" page, showing publications Omonike Olaleye has written about Humans.
Connection Strength
0.558
-
Onyenaka C, Idowu KA, Ha NP, Graviss EA, Olaleye OA. Anti-Tuberculosis Potential of OJT008 against Active and Multi-Drug-Resistant Mycobacterium Tuberculosis: In Silico and In Vitro Inhibition of Methionine Aminopeptidase. Int J Mol Sci. 2023 Dec 05; 24(24).
Score: 0.044
-
Egbejimi A, Ajewole V, Dongarwar D, Kaur M, Phillips M, Liang J, Fadel M, Lota L, Simon J, Otule M, Taylor K, Oguibe G, Salihu HM, Olaleye O. Racial Disparities in Preterm Birth among Pregnant Women with Obesity. South Med J. 2023 06; 116(6):471-477.
Score: 0.042
-
Olaleye OA, Zash R, Diseko M, Mayondi G, Mabuta J, Lockman S, Melton ML, Mmalane M, Makhema J, Shapiro RL. Impact of prophylactic antimalarials in pregnant women living with Human Immunodeficiency Virus?on birth outcomes in Botswana. Trop Med Int Health. 2022 11; 27(11):990-998.
Score: 0.041
-
Tavera G, Dongarwar D, Salemi JL, Akindela O, Osazuwa I, Akpan EB, Okolie U, Johnson M, Spooner KK, Akpan UI, Yusuf KK, Chukwudum C, Salihu HM, Olaleye OA. Diabetes in pregnancy and risk of near-miss, maternal mortality and foetal outcomes in the USA: a retrospective cross-sectional analysis. J Public Health (Oxf). 2022 08 25; 44(3):549-557.
Score: 0.040
-
Olaleye OA, Dongarwar D, Salihu HM, Adu-Gyamfi S, Kaur M, Egbejimi A, Moerchen VA, Belcher HME, Holmes F, Kuo A, Copeland-Linder N, Noble CA, Vamos CA, Waters CR, Brown CM, Reddy MM. HRSA-Funded MCH Pipeline Training Program: Advancing the MCH Pipeline and Workforce Through Research Collaborations. Matern Child Health J. 2022 Aug; 26(Suppl 1):147-155.
Score: 0.040
-
Kehinde IA, Egbejimi A, Kaur M, Onyenaka C, Adebusuyi T, Olaleye OA. Inhibitory mechanism of Ambroxol and Bromhexine Hydrochlorides as potent blockers of molecular interaction between SARS-CoV-2 spike protein and human angiotensin-converting Enzyme-2. J Mol Graph Model. 2022 07; 114:108201.
Score: 0.039
-
Kehinde IA, Egbeyemi A, Kaur M, Onyenaka C, Adebusuyi T, Olaleye OA. Inhibitory mechanism of clioquinol and its derivatives at the exopeptidase site of human angiotensin-converting enzyme-2 and receptor binding domain of SARS-CoV-2 viral spike. J Biomol Struct Dyn. 2023 04; 41(7):2992-3001.
Score: 0.039
-
Thompson J, Onyenaka C, Oduguwa E, Dongarwar D, Gendra S, Coker V, Kutse S, Blanco M, Nwangwu O, King C, Enamorado E, Bakare O, Ajewole VB, Spooner KK, Salemi JL, Aliyu MH, Salihu HM, Olaleye OA. Trends and Racial/Ethnic Disparities in the Rates of Pre-eclampsia by HIV Status in the US. J Racial Ethn Health Disparities. 2021 06; 8(3):670-677.
Score: 0.035
-
Salihu H, Dongarwar D, Ikedionwu CA, Shelton A, Jenkins CM, Onyenaka C, Charles C, Wang H, Osemene I, Harris KJ, Kaur M, Rasmus M, Awosemo O, Milton S, Estill S, Adebusuyi T, Gao X, Mbye YFN, Chen Y, Olaleye OA. Racial/Ethnic Disparities in the Burden of HIV/Cervical Cancer Comorbidity and Related In-hospital Mortality in the USA. J Racial Ethn Health Disparities. 2021 02; 8(1):24-32.
Score: 0.034
-
John SF, Aniemeke E, Ha NP, Chong CR, Gu P, Zhou J, Zhang Y, Graviss EA, Liu JO, Olaleye OA. Characterization of 2-hydroxy-1-naphthaldehyde isonicotinoyl hydrazone as a novel inhibitor of methionine aminopeptidases from Mycobacterium tuberculosis. Tuberculosis (Edinb). 2016 12; 101S:S73-S77.
Score: 0.027
-
Olaleye O, Raghunand TR, Bhat S, Chong C, Gu P, Zhou J, Zhang Y, Bishai WR, Liu JO. Characterization of clioquinol and analogues as novel inhibitors of methionine aminopeptidases from Mycobacterium tuberculosis. Tuberculosis (Edinb). 2011 Dec; 91 Suppl 1:S61-5.
Score: 0.019
-
Olaleye O, Raghunand TR, Bhat S, He J, Tyagi S, Lamichhane G, Gu P, Zhou J, Zhang Y, Grosset J, Bishai WR, Liu JO. Methionine aminopeptidases from Mycobacterium tuberculosis as novel antimycobacterial targets. Chem Biol. 2010 Jan 29; 17(1):86-97.
Score: 0.017
-
Olaleye OA, Bishai WR, Liu JO. Targeting the role of N-terminal methionine processing enzymes in Mycobacterium tuberculosis. Tuberculosis (Edinb). 2009 Dec; 89 Suppl 1:S55-9.
Score: 0.017
-
Dongarwar D, Ajewole V, Spooner KK, Tran V, Adebusuyi T, Onyenaka C, Bakare O, Emeh C, Baines K, Boua D, Mossi Y, Egbejimi A, Ibrahim S, Olaleye O, Salihu HM. Racial and Ethnic Disparities in Stillbirth among Pregnant Women with Obesity. Am J Perinatol. 2024 05; 41(S 01):e2138-e2144.
Score: 0.011
-
Fernandes P, Wang K, Timmerman J, Reyes A, Holmes F, Olaleye OA, Salihu HM, Moerchen VA, Belcher HME, Copeland-Linder N, Noble CA, Vamos CA, Armstrong A, Waters CR, Long-White D, Brown C, Reddy MM, Kuo A. Success of Maternal and Child Health Pipeline Training Programs: Alumni Survey Results. Matern Child Health J. 2022 Aug; 26(Suppl 1):69-77.
Score: 0.010
-
Belcher HME, Copeland-Linder N, Stone J, Waters CR, Kuo A, Moerchen V, Olaleye O, Salihu HM, Vamos C, Brown C, Reddy MM. MCH Pipeline Training Program: Connecting with Academia to Build Capacity Through Mentoring. Matern Child Health J. 2022 Aug; 26(Suppl 1):37-43.
Score: 0.010
-
Fernandes P, Wang K, Timmerman J, Reyes A, Holmes F, Olaleye OA, Salihu HM, Moerchen VA, Belcher HME, Copeland-Linder N, Noble CA, Vamos CA, Armstrong A, Waters CR, Long-White D, Brown C, Reddy MM, Kuo A. Success of Maternal and Child Health Pipeline Training Programs: Alumni Survey Results. Matern Child Health J. 2022 Jul; 26(7):1415-1423.
Score: 0.010
-
Darlington F, Acha BM, Roshan T, Ikeanyionwu C, Kutse S, Abajue U, Osazuwa B, Gomez I, Spooner KK, Salemi JL, Dongarwar D, Olaleye OA, Salihu HM, Ndefo UA. Opioid-Related Disorders Among Pregnant Women with Sickle Cell Disease and Adverse Pregnancy Outcomes. Pain Med. 2020 11 01; 21(11):3087-3093.
Score: 0.009
-
Dongarwar D, Taylor J, Ajewole V, Anene N, Omoyele O, Ogba C, Oluwatoba A, Giger D, Thuy A, Argueta E, Naik E, Salemi JL, Spooner K, Olaleye O, Salihu HM. Trends in Appendicitis Among Pregnant Women, the Risk for Cardiac Arrest, and Maternal-Fetal Mortality. World J Surg. 2020 Dec; 44(12):3999-4005.
Score: 0.009
-
Nguyen NH, Le EN, Mbah VO, Welsh EB, Daas R, Spooner KK, Salemi JL, Olaleye OA, Salihu HM. Opioid Use Among HIV-Positive Pregnant Women and the Risk for Maternal-Fetal Complications. South Med J. 2020 06; 113(6):292-297.
Score: 0.009
-
Ekpenyong O, Gao X, Ma J, Cooper C, Nguyen L, Olaleye OA, Liang D, Xie H. Pre-Clinical Pharmacokinetics, Tissue Distribution and Physicochemical Studies of CLBQ14, a Novel Methionine Aminopeptidase Inhibitor for the Treatment of Infectious Diseases. Drug Des Devel Ther. 2020; 14:1263-1277.
Score: 0.008
-
Erwin ER, Addison AP, John SF, Olaleye OA, Rosell RC. Pharmacokinetics of isoniazid: The good, the bad, and the alternatives. Tuberculosis (Edinb). 2019 05; 116S:S66-S70.
Score: 0.008
-
Salihu HM, Henshaw C, Salemi JL, Dongarwar D, Wudil UJ, Olaleye O, Godbole N, Aggarwal A, Aliyu MH. Temporal trends and black-white disparity in mortality among hospitalized persons living with HIV in the United States. Medicine (Baltimore). 2019 Mar; 98(9):e14584.
Score: 0.008
-
Dennis EM, Hao Y, Tamambang M, Roshan TN, Gatlin KJ, Bghigh H, Ogunyemi OT, Diallo F, Spooner KK, Salemi JL, Olaleye OA, Khan KZ, Aliyu MH, Salihu HM. Tuberculosis during pregnancy in the United States: Racial/ethnic disparities in pregnancy complications and in-hospital death. PLoS One. 2018; 13(3):e0194836.
Score: 0.007
-
Prophet J, Kelly K, Domingo J, Ayeni H, Mekouguem XPD, Dockery B, Allam F, Kaur M, Artis J, Spooner KK, Salemi JL, Olaleye OA, Salihu HM. Severe pre-eclampsia among pregnant women with sickle cell disease and HIV. Pregnancy Hypertens. 2018 Jan; 11:87-91.
Score: 0.007
-
Fernandez D, Salami I, Davis J, Mbah F, Kazeem A, Ash A, Babino J, Carter L, Salemi JL, Spooner KK, Olaleye OA, Salihu HM. HIV-TB Coinfection among 57 Million Pregnant Women, Obstetric Complications, Alcohol Use, Drug Abuse, and Depression. J Pregnancy. 2018; 2018:5896901.
Score: 0.007
-
Falana A, Akpojiyovwi V, Sey E, Akpaffiong A, Agumbah O, Chienye S, Banks J, Jones E, Spooner KK, Salemi JL, Olaleye OA, Onyiego SD, Salihu HM. Hospital length of stay and cost burden of HIV, tuberculosis, and HIV-tuberculosis coinfection among pregnant women in the United States. Am J Infect Control. 2018 05; 46(5):564-570.
Score: 0.007
-
Vijayakumar S, Finney John S, Nusbaum RJ, Ferguson MR, Cirillo JD, Olaleye O, Endsley JJ. In vitro model of mycobacteria and HIV-1 co-infection for drug discovery. Tuberculosis (Edinb). 2013 Dec; 93 Suppl:S66-70.
Score: 0.005